Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 11 - 20 of about 179   

Articles published

AZN 4,293.50 -41.00 (-0.95%)
price chart
AstraZeneca plc (AZN) � Research Analysts' Recent Ratings Updates
AstraZeneca plc was upgraded by analysts at Jefferies Group to a �buy� rating. They now have a GBX 5,000 ($80.46) price target on the stock, up previously from GBX 4,500 ($72.42).
3 Stocks To Beat The FTSE 100: Unilever plc, AstraZeneca plc And British ...
Over the last month, the FTSE 100 has fallen by 4.5%. This is a significant fall in a short period of time and shows that, while the global economy may be moving in the right direction, stock market corrections are a very real threat to investors ...
Can AstraZeneca plc Help You To Retire Rich?
It's been an incredible turnaround for investors in AstraZeneca (LSE: AZN) (NYSE: AZN.US) in recent years. Indeed, after posting next to no share price gains between 2010 and 2013, shares in the pharmaceutical major have risen by 49% since the start of ...
3 Stocks To Avoid In A Plunging Market: AstraZeneca plc, Centrica PLC ...
The FTSE 100 index rallied on Friday and is in positive territory on Monday after two volatile trading sessions last week. Shareholders of AstraZeneca (LSE: AZN), Centrica (LSE: CNA) and Thomas Cook (LSE: TCG) are going to be in trouble if market ...
Is AstraZeneca plc A Safe Dividend Investment?
At a share price of 4351p the firm's forward P/E rating stands at just under 18 for 2015, which seems high for a company expected to show a decline in earnings of 7% that year.
3 Neil Woodford Plays On Ageing Populations: AstraZeneca plc, Smith ...
WOODFORD Ace fund manager Neil Woodford has hammered the market over a quarter of a century. Much of his success has come from seeing 'the big picture' - and pumping money into sectors that have delivered juicy returns, while avoiding those that ...
GlaxoSmithKline plc Is Still A Better Pick Than AstraZeneca plc
AstraZeneca It has been a terrible year for GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) and more bad news could be around the corner.
Related articles »  
AstraZeneca plc's "Neutral" Rating Reiterated at Credit Suisse (AZN)
AstraZeneca plc (ADR) logo Credit Suisse reissued their neutral rating on shares of AstraZeneca plc (NYSE:AZN) in a research report released on Thursday morning.
AstraZeneca plc Given Average Rating of "Hold" by Analysts (LON:AZN)  Ticker Report
AstraZeneca plc Rating Reiterated by Deutsche Bank (AZN)  sleekmoney
Related articles »  
AstraZeneca plc Rating Reiterated by Credit Suisse (AZN)
AstraZeneca plc logo Credit Suisse reissued their neutral rating on shares of AstraZeneca plc (LON:AZN) in a research note released on Thursday morning.
Nordea Equity Research Reiterates Buy Rating for AstraZeneca plc (AZN)  sleekmoney
Morningstar Assigns "AA-" Credit Rating to AstraZeneca plc (AZN)  Watch List News (press release)
Related articles »  
Weekly Analysts' Ratings Changes for AstraZeneca plc (AZN)
AstraZeneca plc was upgraded by analysts at Jefferies Group from a �hold� rating to a �buy� rating. AstraZeneca plc was upgraded by analysts at Bank of America from a �neutral� rating to a �buy� rating. AstraZeneca plc had its �neutral� rating ...